A Study of ZW171 in Participants with Advanced or Metastatic Mesothelin Expressing Cancers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511119-11-00

Acronym

ZWI-ZW171-101

Enrollment

Registered

2024-10-17

Start date

2025-03-07

Completion date

2025-10-01

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or metastatic ovarian cancer, and other mesothelin expressing cancers, NSCLC, pancreatic cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026